Cogent Biosciences, Inc. (COGT)
COGT Stock Price Chart
Explore Cogent Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze COGT price movements and trends.
COGT Company Profile
Discover essential business fundamentals and corporate details for Cogent Biosciences, Inc. (COGT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
29 Mar 2018
Employees
205.00
Website
https://www.cogentbio.comCEO
Andrew R. Robbins
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
COGT Financial Timeline
Browse a chronological timeline of Cogent Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 23 Feb 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.56.
Earnings released on 5 Aug 2025
EPS came in at -$0.53 surpassing the estimated -$0.55 by +3.64%.
Earnings released on 6 May 2025
EPS came in at -$0.52 surpassing the estimated -$0.56 by +7.14%.
Earnings released on 25 Feb 2025
EPS came in at -$0.09 surpassing the estimated -$0.59 by +84.75%.
Earnings released on 12 Nov 2024
EPS came in at -$0.64 falling short of the estimated -$0.55 by -16.36%.
Earnings released on 6 Aug 2024
EPS came in at -$0.59 falling short of the estimated -$0.55 by -7.27%.
Earnings released on 7 May 2024
EPS came in at -$0.62 falling short of the estimated -$0.50 by -24.00%.
Earnings released on 26 Feb 2024
EPS came in at -$0.63 falling short of the estimated -$0.54 by -16.67%, while revenue for the quarter reached $5.59M .
Earnings released on 2 Nov 2023
EPS came in at -$0.64 falling short of the estimated -$0.50 by -28.00%.
Earnings released on 8 Aug 2023
EPS came in at -$0.59 falling short of the estimated -$0.53 by -11.32%.
Earnings released on 9 May 2023
EPS came in at -$0.54 surpassing the estimated -$0.58 by +6.90%.
Earnings released on 14 Mar 2023
EPS came in at -$0.56 falling short of the estimated -$0.50 by -12.00%.
Earnings released on 14 Nov 2022
EPS came in at -$0.50 surpassing the estimated -$0.51 by +1.96%.
Earnings released on 9 Aug 2022
EPS came in at -$0.71 falling short of the estimated -$0.64 by -10.94%.
Earnings released on 10 May 2022
EPS came in at -$0.68 falling short of the estimated -$0.53 by -28.30%.
Earnings released on 15 Mar 2022
EPS came in at -$0.61 falling short of the estimated -$0.55 by -10.91%.
Earnings released on 10 Nov 2021
EPS came in at -$0.48 falling short of the estimated -$0.43 by -11.63%.
Earnings released on 16 Aug 2021
EPS came in at -$0.43 falling short of the estimated -$0.39 by -10.26%.
Earnings released on 12 May 2021
EPS came in at -$0.34 surpassing the estimated -$0.46 by +26.09%.
Earnings released on 16 Mar 2021
EPS came in at -$6.03 falling short of the estimated -$0.30 by -1.91K%, while revenue for the quarter reached $0.00 .
Earnings released on 9 Nov 2020
EPS came in at -$1.04 falling short of the estimated -$0.76 by -36.84%, while revenue for the quarter reached $312.00K , missing expectations by -84.25%.
Stock split effective on 9 Nov 2020
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
COGT Stock Performance
Access detailed COGT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.